Bank of America’s Reviva Pharmaceuticals RVPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $166 | Buy |
436
+84
| +24% | +$32 | ﹤0.01% | 6834 |
|
|
2025
Q1 | $335 | Buy |
352
+31
| +10% | +$30 | ﹤0.01% | 6537 |
|
|
2024
Q4 | $581 | Buy |
321
+106
| +49% | +$192 | ﹤0.01% | 6457 |
|
|
2024
Q3 | $310 | Sell |
215
-3,730
| -95% | -$5.38K | ﹤0.01% | 6547 |
|
|
2024
Q2 | $5.05K | Sell |
3,945
-17,984
| -82% | -$23K | ﹤0.01% | 6115 |
|
|
2024
Q1 | $82.9K | Buy |
21,929
+6,943
| +46% | +$26.2K | ﹤0.01% | 5475 |
|
|
2023
Q4 | $77.2K | Buy |
14,986
+14,985
| +1,498,500% | +$77.2K | ﹤0.01% | 5554 |
|
|
2023
Q3 | $5 | Sell |
1
-191
| -99% | -$955 | ﹤0.01% | 6732 |
|
|
2023
Q2 | $1.13K | Buy |
192
+191
| +19,100% | +$1.12K | ﹤0.01% | 6333 |
|
|
2023
Q1 | $4 | Sell |
1
-33
| -97% | -$132 | ﹤0.01% | 6852 |
|
|
2022
Q4 | $144 | Buy |
34
+33
| +3,300% | +$140 | ﹤0.01% | 6784 |
|
|
2022
Q3 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 7137 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 7347 |
|
|
2022
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 7663 |
|
|
2021
Q4 | $0 | Sell |
2
-24,804
| -100% | – | ﹤0.01% | 7562 |
|
|
2021
Q3 | $101K | Buy |
+24,806
| New | +$101K | ﹤0.01% | 5852 |
|
|
2020
Q2 | – | Sell |
-331,000
| Closed | -$3.48M | – | 6368 |
|
|
2020
Q1 | $3.48M | Hold |
331,000
| – | – | ﹤0.01% | 2683 |
|
|
2019
Q4 | $3.47M | Hold |
331,000
| – | – | ﹤0.01% | 3068 |
|
|
2019
Q3 | $3.43M | Hold |
331,000
| – | – | ﹤0.01% | 3042 |
|
|
2019
Q2 | $3.38M | Buy |
+331,000
| New | +$3.38M | ﹤0.01% | 3083 |
|